SINGAPORE, Sept. 12, 2024 /PRNewswire/ -- Qritive, a leading
digital pathology and AI company headquartered in Singapore, is proud to announce its
collaboration with Roche, one of the largest diagnostics and life
sciences companies in the world. This collaboration represents a
significant milestone to advance cancer diagnostics and treatment
and accelerate adoption of AI by pathologists.
With Qritive's AI-powered solutions fully integrated with
Roche navify® Digital Pathology platform, pathologists
can leverage AI technology to diagnose cancer more accurately and
efficiently, leading to reduced time to treatment and enhanced
patient outcomes. These clinically validated AI modules, designed
for colon, prostate, breast, and gastric cancers, analyze whole
slide images to identify and grade tumor with precision. These
tools have been shown to improve pathology reporting time by up to
10-fold and reduce the risk of misdiagnosis dramatically.
As Bruno Occhipinti, CEO of
Qritive, puts it, "we are truly excited to see how the integration
of our AI-powered solutions within the highly performing Roche
navify® Digital Pathology platform will augment
pathologists' performance, enabling affordable and accurate
diagnostics at scale."
Qritive's collaboration with Roche reinforces its commitment to
empowering pathologists globally with state-of-the-art AI-powered
solutions and alleviating the pressure on the healthcare system. By
bringing its innovative AI-based pathology solutions to a broader
audience, Qritive continues to play a pivotal role in the future of
cancer diagnostics.
For more information about Qritive and its AI-powered solutions,
please visit www.qritive.com or contact info@qritive.com.
About Qritive:
Headquartered in Singapore,
with operations in the US and India, Qritive is a breakthrough Artificial
Intelligence (AI) solution developer that is advancing digital
pathology for cancer diagnosis and improving health outcomes.
Qritive leverages deep learning technology to support the
interpretation of pathology tests for time and resource-strapped
pathologists, enabling faster diagnosis and reducing time to
treatment for patients. Qritive is dedicated to empowering
healthcare professionals across the globe with AI-powered solutions
to operate collaboratively at the peak of their performance despite
complexity and distance.
Photo - https://mma.prnewswire.com/media/2502765/Image.jpg
Logo -
https://mma.prnewswire.com/media/2502766/Qritive_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/qritive-joins-forces-with-roche-to-redefine-global-cancer-diagnostics-with-ai-302245489.html